Published in Ann Intern Med on December 01, 1983
A randomized study of pegylated liposomal doxorubicin versus continuous-infusion doxorubicin in elderly patients with acute lymphoblastic leukemia: the GRAALL-SA1 study. Haematologica (2010) 0.81
Phase I study of 21 days continuous infusion with vindesine. Br J Cancer (1989) 0.75
Simplifying infusion chemotherapy: preliminary communication. J R Soc Med (1988) 0.75
A phase II study of cisplatin, vindesine and continuously infused 5-fluorouracil in the treatment of advanced non-small-cell lung cancer. Osaka Lung Cancer Chemotherapy Study Group. Br J Cancer (1996) 0.75
A methodology for determining patients' eligibility for clinical trials. Methods Inf Med (1993) 4.38
Isotopic tracking of change in diet and habitat use in african elephants. Science (1995) 4.27
142Nd evidence for early (>4.53 Ga) global differentiation of the silicate Earth. Science (2005) 3.52
Relation between tumour response to first-line chemotherapy and survival in advanced colorectal cancer: a meta-analysis. Meta-Analysis Group in Cancer. Lancet (2000) 3.27
T-HELPER: automated support for community-based clinical research. Proc Annu Symp Comput Appl Med Care (1992) 2.98
Supportive-expressive group therapy and distress in patients with metastatic breast cancer: a randomized clinical intervention trial. Arch Gen Psychiatry (2001) 2.51
Mechanisms of action of and resistance to antitubulin agents: microtubule dynamics, drug transport, and cell death. J Clin Oncol (1999) 2.43
Comparison of clinical assessment with APACHE II for predicting mortality risk in patients admitted to a medical intensive care unit. JAMA (1988) 2.32
Detection of cell-affecting agents with a silicon biosensor. Science (1989) 2.31
Heterogeneity of Rhizobium lipopolysaccharides. J Bacteriol (1984) 2.27
Modulation of fluorouracil by leucovorin in patients with advanced colorectal cancer: an updated meta-analysis. J Clin Oncol (2004) 2.24
A therapy planning architecture that combines decision theory and artificial intelligence techniques. Comput Biomed Res (1987) 2.09
A 2-O-methylfucose moiety is present in the lipo-oligosaccharide nodulation signal of Bradyrhizobium japonicum. Proc Natl Acad Sci U S A (1992) 2.09
Snake venom poisoning in the United States. Experiences with 550 cases. JAMA (1975) 2.01
Improvements in data collection through physician use of a computer-based chemotherapy treatment consultant. J Clin Oncol (1985) 2.01
Association of hypomagnesemia and mortality in acutely ill medical patients. Crit Care Med (1993) 1.85
Structure of lipid A component of Rhizobium leguminosarum bv. phaseoli lipopolysaccharide. Unique nonphosphorylated lipid A containing 2-amino-2-deoxygluconate, galacturonate, and glucosamine. J Biol Chem (1994) 1.82
Rapid correction of hypokalemia using concentrated intravenous potassium chloride infusions. Arch Intern Med (1990) 1.81
The (alpha2-->8)-linked polysialic acid capsule and lipooligosaccharide structure both contribute to the ability of serogroup B Neisseria meningitidis to resist the bactericidal activity of normal human serum. Infect Immun (1998) 1.78
Impact of omeprazole on the plasma clearance of methotrexate. Cancer Chemother Pharmacol (1993) 1.73
Structural characterization of the Pseudomonas aeruginosa 1244 pilin glycan. J Biol Chem (2001) 1.67
Suppression of the Fix- phenotype of Rhizobium meliloti exoB mutants by lpsZ is correlated to a modified expression of the K polysaccharide. J Bacteriol (1995) 1.66
Occurrence of lipid A variants with 27-hydroxyoctacosanoic acid in lipopolysaccharides from members of the family Rhizobiaceae. J Bacteriol (1991) 1.65
Decreased mutation rate for cellular resistance to doxorubicin and suppression of mdr1 gene activation by the cyclosporin PSC 833. J Natl Cancer Inst (1995) 1.60
Impact of critical care physician staffing on patients with septic shock in a university hospital medical intensive care unit. JAMA (1988) 1.59
Alteration of etoposide pharmacokinetics and pharmacodynamics by cyclosporine in a phase I trial to modulate multidrug resistance. J Clin Oncol (1992) 1.49
Salts on Europa's surface detected by Galileo's near infrared mapping spectrometer. The NIMS Team. Science (1998) 1.49
The presence of a novel type of surface polysaccharide in Rhizobium meliloti requires a new fatty acid synthase-like gene cluster involved in symbiotic nodule development. Mol Microbiol (1993) 1.45
The structures of the lipopolysaccharides from Rhizobium etli strains CE358 and CE359. The complete structure of the core region of R. etli lipopolysaccharides. J Biol Chem (1998) 1.45
The role of physician-assistants in critical care units. Chest (1991) 1.44
Multidrug (pleiotropic) resistance in doxorubicin-selected variants of the human sarcoma cell line MES-SA. Cancer Res (1985) 1.43
Low or absent SPARC expression in acute myeloid leukemia with MLL rearrangements is associated with sensitivity to growth inhibition by exogenous SPARC protein. Leukemia (2006) 1.42
Production of cell-associated polysaccharides of Rhizobium fredii USDA205 is modulated by apigenin and host root extract. Mol Plant Microbe Interact (1994) 1.42
A randomized controlled trial of filgrastim as an adjunct to antibiotics for treatment of hospitalized patients with community-acquired pneumonia. CAP Study Group. J Infect Dis (1998) 1.41
Oligosaccharins--oligosaccharides that regulate growth, development and defence responses in plants. Glycobiology (1992) 1.41
A special acyl carrier protein for transferring long hydroxylated fatty acids to lipid A in Rhizobium. J Biol Chem (1996) 1.40
Multifactorial mechanisms associated with broad cross-resistance of ovarian carcinoma cells selected by cyanomorpholino doxorubicin. Cancer Res (1991) 1.39
Quality of death after discontinuation of dialysis. Arch Intern Med (1995) 1.38
The importance of the lumpectomy surgical margin status in long-term results of breast conservation. Cancer (1995) 1.37
Phase I and pharmacokinetic study of lexatumumab (HGS-ETR2) given every 2 weeks in patients with advanced solid tumors. Ann Oncol (2009) 1.33
Gastrin releasing peptide is a selective mitogen for small cell lung carcinoma in vitro. J Clin Invest (1985) 1.33
Novel rkp gene clusters of Sinorhizobium meliloti involved in capsular polysaccharide production and invasion of the symbiotic nodule: the rkpK gene encodes a UDP-glucose dehydrogenase. J Bacteriol (1998) 1.32
Interaction of anti-HIV protease inhibitors with the multidrug transporter P-glycoprotein (P-gp) in human cultured cells. J Acquir Immune Defic Syndr Hum Retrovirol (1998) 1.32
Lipid A and O-chain modifications cause Rhizobium lipopolysaccharides to become hydrophobic during bacteroid development. Mol Microbiol (2001) 1.30
Multidrug resistance (mdr1) gene expression in adult acute leukemias: correlations with treatment outcome and in vitro drug sensitivity. Blood (1991) 1.29
Prevalence and clinical implications of hypocalcemia in acutely ill patients in a medical intensive care setting. Am J Med (1988) 1.28
Modulation of multidrug resistance: at the threshold. J Clin Oncol (1993) 1.28
Is the placebo powerless? N Engl J Med (2001) 1.26
A lipopolysaccharide mutant of Bradyrhizobium japonicum that uncouples plant from bacterial differentiation. Mol Plant Microbe Interact (1992) 1.25
Phase I trial of doxorubicin with cyclosporine as a modulator of multidrug resistance. J Clin Oncol (1994) 1.25
Two glycosyltransferase genes, lgtF and rfaK, constitute the lipooligosaccharide ice (inner core extension) biosynthesis operon of Neisseria meningitidis. J Bacteriol (1996) 1.25
Inner core biosynthesis of lipooligosaccharide (LOS) in Neisseria meningitidis serogroup B: identification and role in LOS assembly of the alpha1,2 N-acetylglucosamine transferase (RfaK). J Bacteriol (1996) 1.24
Isolation and partial characterization of the extracellular polysaccharides and lipopolysaccharides from fast-growing Rhizobium japonicum USDA 205 and its Nod- mutant, HC205, which lacks the symbiotic plasmid. Appl Environ Microbiol (1985) 1.23
Resistance mechanisms in human sarcoma mutants derived by single-step exposure to paclitaxel (Taxol). Cancer Res (1996) 1.23
Lipid A biosynthesis in Rhizobium leguminosarum: role of a 2-keto-3-deoxyoctulosonate-activated 4' phosphatase. Proc Natl Acad Sci U S A (1995) 1.22
Management of breast cancer after Hodgkin's disease. J Clin Oncol (2000) 1.21
Heterogeneous accretion and the moderately volatile element budget of Earth. Science (2010) 1.20
Distribution and phylogenetic significance of 27-hydroxy-octacosanoic acid in lipopolysaccharides from bacteria belonging to the alpha-2 subgroup of Proteobacteria. Int J Syst Bacteriol (1991) 1.16
Prevalence of multidrug resistance related to activation of the mdr1 gene in human sarcoma mutants derived by single-step doxorubicin selection. Cancer Res (1994) 1.16
Pharmacokinetics and protein binding of cis-dichlorodiammine platinum (II) administered as a one hour or as a twenty hour infusion. Cancer Chemother Pharmacol (1980) 1.16
27-Hydroxyoctacosanoic acid is a major structural fatty acyl component of the lipopolysaccharide of Rhizobium trifolii ANU 843. J Biol Chem (1989) 1.16
Resistance to nodulation of cv. Afghanistan peas is overcome by nodX, which mediates an O-acetylation of the Rhizobium leguminosarum lipo-oligosaccharide nodulation factor. Mol Microbiol (1993) 1.16
The early evolution of the inner solar system: a meteoritic perspective. Science (2001) 1.15
The effect of fluid loading, blood transfusion, and catecholamine infusion on oxygen delivery and consumption in patients with sepsis. Am Rev Respir Dis (1986) 1.14
The lipooligosaccharide (LOS) of Neisseria meningitidis serogroup B strain NMB contains L2, L3, and novel oligosaccharides, and lacks the lipid-A 4'-phosphate substituent. Carbohydr Res (1998) 1.14
Bradyrhizobium japonicum nodD1 can be specifically induced by soybean flavonoids that do not induce the nodYABCSUIJ operon. J Biol Chem (1992) 1.14
The rkpGHI and -J genes are involved in capsular polysaccharide production by Rhizobium meliloti. J Bacteriol (1997) 1.13
Multidrug resistance in lymphomas. J Clin Oncol (1994) 1.13
Isolation and characterization of the lipopolysaccharides from Bradyrhizobium japonicum. J Bacteriol (1990) 1.12
A novel relationship between O-antigen variation, matrix formation, and invasiveness of Salmonella enteritidis. Epidemiol Infect (1996) 1.12
Expression of Rhizobium leguminosarum CFN42 genes for lipopolysaccharide in strains derived from different R. leguminosarum soil isolates. J Bacteriol (1990) 1.12
Biosynthesis of a structurally novel lipid A in Rhizobium leguminosarum: identification and characterization of six metabolic steps leading from UDP-GlcNAc to 3-deoxy-D-manno-2-octulosonic acid2-lipid IVA. J Bacteriol (1994) 1.11
Toward reusable software components at the point of care. Proc AMIA Annu Fall Symp (1996) 1.11
Chemical characterization of pH-dependent structural epitopes of lipopolysaccharides from Rhizobium leguminosarum biovar phaseoli. J Bacteriol (1992) 1.10
Novel mechanism of resistance to paclitaxel (Taxol) in human K562 leukemia cells by combined selection with PSC 833. Oncol Res (1995) 1.09
Toward an interim standard for patient-centered knowledge-access. Proc Annu Symp Comput Appl Med Care (1993) 1.09
A close-up look at Io from Galileo's near-infrared mapping spectrometer. Science (2000) 1.07
Cooperative action of lipo-chitin nodulation signals on the induction of the early nodulin, ENOD2, in soybean roots. Mol Plant Microbe Interact (1996) 1.07
Clinical studies with modulators of multidrug resistance. Hematol Oncol Clin North Am (1995) 1.06
Varying the abundance of O antigen in Rhizobium etli and its effect on symbiosis with Phaseolus vulgaris. J Bacteriol (2000) 1.06
Absolute measurement of the extreme UV solar flux. Appl Opt (1984) 1.06
Pulmonary edema following intracranial hemorrhage. Chest (1979) 1.06
Clinical trials of modulation of multidrug resistance. Pharmacokinetic and pharmacodynamic considerations. Cancer (1993) 1.05
A new core tetrasaccharide component from the lipopolysaccharide of Rhizobium trifolii ANU 843. J Biol Chem (1989) 1.05
Treatment of refractory and relapsed acute myelogenous leukemia with combination chemotherapy plus the multidrug resistance modulator PSC 833 (Valspodar). Blood (1999) 1.03
Development and characterization of a human sarcoma cell line, MES-SA, sensitive to multiple drugs. Cancer Res (1983) 1.02
Improved therapeutic index of bleomycin when administered by continuous infusion in mice. Cancer Treat Rep (1978) 1.02
Fluid loading increases oxygen consumption in septic patients with lactic acidosis. Am Rev Respir Dis (1985) 1.02
Treatment of angioimmunoblastic T-cell lymphoma with cyclosporine. Ann Oncol (1997) 1.01
Phase I trial of etoposide with cyclosporine as a modulator of multidrug resistance. J Clin Oncol (1992) 1.01
Significance of blood lactate levels in critically ill patients with liver disease. Am J Med (1987) 1.01
Pulmonary toxicity of antitumor agents. Cancer Treat Rev (1983) 1.00
Coccidioidomycosis: an update. Hosp Pract (1995) (1998) 1.00
The effect of heavy metals on plants II. Net photosynthesis and transpiration of whole corn and sunflower plants treated with Pb, Cd, and Tl. Environ Res (1975) 0.99
Verapamil-mediated sensitization of doxorubicin-selected pleiotropic resistance in human sarcoma cells: selectivity for drugs which produce DNA scission. Cancer Res (1986) 0.99
South-polar features on Venus similar to those near the north pole. Nature (2007) 0.98
Genetic locus required for antigenic maturation of Rhizobium etli CE3 lipopolysaccharide. J Bacteriol (2001) 0.98
Left ventricular diastolic function in sepsis. Crit Care Med (1990) 0.98